Lenalidomide Maintenance Prolongs PFS in Elderly DLBCL
December 13th 2016For the first time, a study shows that using an immunomodulatory agent as maintenance therapy prolongs progression-free survival for patients with diffuse large B-cell lymphoma after first-line treatment with rituximab plus CHOP.